An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
Public ClinicalTrials.gov record NCT03844048. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03844048
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Interventions
- Venetoclax Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 5, 2019
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
- Last update posted
- Mar 19, 2026
2019 – 2027
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona Cancer Center - Tucson /ID# 210548 | Tucson | Arizona | 85724 | — |
| UCLA Santa Monica Hematology Oncology /ID# 210551 | Los Angeles | California | 90095 | — |
| Ingalls Memorial Hosp /ID# 210553 | Harvey | Illinois | 60426 | — |
| Dana-Farber Cancer Institute /ID# 215360 | Boston | Massachusetts | 02215 | — |
| University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 231132 | Ann Arbor | Michigan | 48109 | — |
| Dartmouth-Hitchcock Medical Center /ID# 210555 | Lebanon | New Hampshire | 03756 | — |
| Swedish Medical Center - Seattle /ID# 213120 | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03844048, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2026 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03844048 live on ClinicalTrials.gov.